Biosurgery Market Research Report – Forecast to 2030

Biosurgery Market Size, Growth and Analysis by Product (Bone-Graft Substitutes, Hemostatic Agents, Soft-Tissue Attachments, and Others), Source (Biological Products, Synthetic Products), Application (Neurological Surgery and Others)—Global Forecast till 2030

ID: MRFR/MED/4785-HCR | August 2022 | Region: Global | 100 Pages         

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Biosurgery Market, by Product

6.1 Introduction

6.2 Bone-Graft Substitutes

6.2.1 Demineralized Bone Matrix

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.2 Synthetic Bone Grafts

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.3 Bone Morphogenetic Proteins

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.4 Other Bone-Graft Substitutes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3 Hemostatic Agents

6.3.1 Thrombin-Based Hemostatic Agents

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.2 Oxidized Regenerated Cellulose-Based Hemostatic Agents

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3.3 Combination Hemostatic Agents

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.4 Soft-Tissue Attachments

6.4.1 Synthetic Meshes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.4.2 Biological Meshes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.5 Surgical Sealants and Adhesives

6.5.1 Natural Sealants and Adhesives

6.5.1.1 Fibrin Sealants

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.5.1.2 Collagen-Based Sealants

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.5.1.3 Gelatin-Based Sealants

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.5.1.4 Albumin-Based Sealants

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.5.1.5 Other Natural Sealants

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.5.2 Synthetic Sealants and Adhesives

6.5.2.1 Peg Hydrogels

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.5.2.2 Cyanoacrylate-Based Sealants and Adhesives

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.5.2.3 Urethane-Based Sealants and Adhesives

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.5.2.4 Other Synthetic Sealants and Adhesives

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.6 Adhesion Barriers

6.6.1 Synthetic Adhesion Barriers

6.6.1.1 Hyaluronic Acid-Based Adhesion Barriers

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.6.1.2 Regenerated Cellulose-Based Adhesion Barriers

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.6.1.3 Peg-Based Adhesion Barriers

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.6.1.4 Ther Synthetic Adhesion Barriers

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.6.2 Natural Adhesion Barriers

6.6.2.1 Collagen & Protein Adhesion Barriers

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.6.2.2 Fibrin-Based Adhesion Barriers

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.7 Staple-Line Reinforcement Agents

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 7. Global Biosurgery Market, by Source

7.1 Introduction

7.2 Biologics Products

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3 Synthetic Products

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 8. Global Biosurgery Market, by Application

8.1 Introduction

8.2 Neurological Surgery

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3 General Surgery

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.4 Cardiovascular Surgery

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.5 Orthopedic Surgery

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.6 Thoracic Surgery

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.7 Gynecology Surgery

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.8 Reconstructive Surgery

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.9 Urology Surgery

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 9. Global Biosurgery Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 B.Braun Melsungen AG

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Baxter International, Inc.

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Johnson & Johnson

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 C.R. Bard

11.4.1 Company Overview

11.4.2 Technology/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Medtronic, PLC.

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 MAQUET Holding B.V. & Co. Kg. (Getinge Group)

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Cohera Medical Inc.

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Integra Lifesciences Holdings Corporation

11.8.1 Overview

11.8.2 Product/ Technology Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Commonwealth Serum Laboratories (CSL)

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Hemostasis, LLC

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Sanofi

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Stryker Corporation

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Pfizer Inc.

11.13.1 Overview

11.13.2 Product Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 Cryolife, Inc.

11.14.1 Overview

11.14.2 Product Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Kuros Biosciences Ltd.

11.15.1 Overview

11.15.2 Product Overview

11.15.3 Financials

11.15.4 Key Developments

11.15.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Biosurgery Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Biosurgery Market Synopsis, 2018–2023

Table 2 Global Biosurgery Market Estimates and Forecast, 2018–2023 (USD Million)

Table 3 Global Biosurgery Market, by Region, 2018–2023 (USD Million)

Table 4 Global Biosurgery Market, by Product, 2018–2023 (USD Million)

Table 5 Global Biosurgery Market, by Source, 2018–2023 (USD Million)

Table 6 Global Biosurgery Market, by Application, 2018–2023 (USD Million)

Table 7 North America: Biosurgery Market, by Product, 2018–2023 (USD

Million)

Table 8 North America: Biosurgery Market, by Source, 2018–2023 (USD

Million)

Table 9 North America: Biosurgery Market, by Application, 2018–2023 (USD

Million)

Table 10 US: Biosurgery Market, by Product, 2018–2023 (USD Million)

Table 11 US: Biosurgery Market, by Source, 2018–2023 (USD Million)

Table 12 US: Biosurgery Market, by Application, 2018–2023 (USD Million)

Table 13 Canada: Biosurgery Market, by Product, 2018–2023 (USD Million)

Table 14 Canada: Biosurgery Market, by Source, 2018–2023 (USD Million)

Table 15 Canada: Biosurgery Market, by Application, 2018–2023 (USD

Million)

Table 16 South America: Biosurgery Market, by Product, 2018–2023 (USD

Million)

Table 17 South America: Biosurgery Market, by Source, 2018–2023 (USD

Million)

Table 18 South America: Biosurgery Market, by Application, 2018–2023 (USD

Million)

Table 19 Europe: Biosurgery Market, by Product, 2018–2023 (USD Million)

Table 20 Europe: Biosurgery Market, by Source, 2018–2023 (USD Million)

Table 21 Europe: Biosurgery Market, by Application, 2018–2023 (USD Million)

Table 22 Western Europe: Biosurgery Market, by Product, 2018–2023 (USD

Million)

Table 23 Western Europe: Biosurgery Market, by Source, 2018–2023 (USD

Million)

Table 24 Western Europe: Biosurgery Market, by Application, 2018–2023

(USD Million)

Table 25 Eastern Europe: Biosurgery Market, by Product, 2018–2023 (USD

Million)

Table 26 Eastern Europe: Biosurgery Market, by Source, 2018–2023 (USD

Million)

Table 27 Eastern Europe: Biosurgery Market, by Application, 2018–2023

(USD Million)

Table 28 Asia-Pacific: Biosurgery Market, by Product, 2018–2023 (USD

Million)

Table 29 Asia-Pacific: Biosurgery Market, by Source, 2018–2023 (USD

Million)

Table 30 Asia-Pacific: Biosurgery Market, by Application, 2018–2023 (USD

Million)

Table 31 Middle East & Africa: Biosurgery Market, by Product, 2018–2023

(USD Million)

Table 32 Middle East & Africa: Biosurgery Market, by Source, 2018–2023

(USD Million)

Table 33 Middle East & Africa: Biosurgery Market, by Application, 2018–2023

(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Biosurgery Market

Figure 3 Segmentation Market Dynamics for Global Biosurgery Market

Figure 4 Global Biosurgery Market Share, by Product, 2020

Figure 5 Global Biosurgery Market Share, by Source, 2020

Figure 6 Global Biosurgery Market Share, by Application, 2020

Figure 7 Global Biosurgery Market Share, by Region, 2020

Figure 8 North America: Biosurgery Market Share, by Country, 2020

Figure 9 Europe: Biosurgery Market Share, by Country, 2020

Figure 10 Asia-Pacific: Biosurgery Market Share, by Country, 2020

Figure 11 Middle East & Africa: Biosurgery Market Share, by Country, 2020

Figure 12 Global Biosurgery Market: Company Share Analysis, 2020 (%)

Figure 13 B.Braun Melsungen AG: Key Financials

Figure 14 B.Braun Melsungen AG: Segmental Revenue

Figure 15 B.Braun Melsungen AG: Geographical Revenue

Figure 16 Baxter International, Inc.: Key Financials

Figure 17 Baxter International, Inc.: Segmental Revenue

Figure 18 Baxter International, Inc.: Geographical Revenue

Figure 19 Johnson & Johnson: Key Financials

Figure 20 Johnson & Johnson: Segmental Revenue

Figure 21 Johnson & Johnson: Geographical Revenue

Figure 22 C.R. Bard: Key Financials

Figure 23 C.R. Bard: Segmental Revenue

Figure 24 C.R. Bard: Geographical Revenue

Figure 25 Medtronic, PLC.: Key Financials

Figure 26 Medtronic, PLC.: Segmental Revenue

Figure 27 Medtronic, PLC.. Geographical Revenue

Figure 28 MAQUET Holding B.V. & Co. Kg. (Getinge Group): Key Financials

Figure 29 MAQUET Holding B.V. & Co. Kg. (Getinge Group): Segmental Revenue

Figure 30 MAQUET Holding B.V. & Co. Kg. (Getinge Group): Geographical Revenue

Figure 31 Cohera Medical Inc.: Key Financials

Figure 32 Cohera Medical Inc.: Segmental Revenue

Figure 33 Cohera Medical Inc.: Geographical Revenue

Figure 34 Integra Lifesciences Holdings Corporation: Key Financials

Figure 35 Integra Lifesciences Holdings Corporation: Segmental Revenue

Figure 36 Integra Lifesciences Holdings Corporation: Geographical Revenue

Figure 37 Commonwealth Serum Laboratories (CSL) : Key Financials

Figure 38 Commonwealth Serum Laboratories (CSL) : Segmental Revenue

Figure 39 Commonwealth Serum Laboratories (CSL) : Geographical Revenue

Figure 40 Hemostasis, LLC: Key Financials

Figure 41 Hemostasis, LLC: Segmental Revenue

Figure 42 Hemostasis, LLC: Geographical Revenue

Figure 43 Sanofi: Key Financials

Figure 44 Sanofi: Segmental Revenue

Figure 45 Sanofi: Geographical Revenue

Figure 46 Stryker Corporation: Key Financials

Figure 47 Stryker Corporation: Segmental Revenue

Figure 48 Stryker Corporation: Geographical Revenue

Figure 49 Pfizer, Inc.: Key Financials

Figure 50 Pfizer, Inc.: Segmental Revenue

Figure 51 Pfizer, Inc.: Geographical Revenue

Figure 52 Cryolife, Inc.: Key Financials

Figure 53 Cryolife, Inc.: Segmental Revenue

Figure 54 Cryolife, Inc.: Geographical Revenue

Figure 55 Kuros Biosciences Ltd.: Key Financials

Figure 56 Kuros Biosciences Ltd.: Segmental Revenue

Figure 57 Kuros Biosciences Ltd.: Geographical Revenue

Biosurgery Market

The global biosurgery market is expected to grow at a CAGR 9.6% during the forecast period 2022-2030

Segmentation

By Product Bone Graft Substitutes Hemostatic Agents Soft Tissue Attachments
By Source Biological Products Synthetic Products
By Application Neurological Surgery

Key Players

  • Baxter International Inc.
  • Braun Melsungen AG
  • R. Bard
  • Johnson & Johnson
  • Medtronic PLC.
  • MAQUET Holding B.V. & Co. Kg. (Getinge Group)
  • Cohera Medical Inc.
  • Integra Lifesciences Holdings Corporation
  • Commonwealth Serum Laboratories (CSL)
  • Hemostasis LLC

Drivers

  • Growing geriatric population
  • an increasing number of surgeries
  • Rising occurrences of trauma and sports-related injuries
Speak to Analyst Request a Free Sample

Biosurgery Market Overview
 
Biosurgery market is expected to grow during the forecast period (2022-2030) at a CAGR 8.40%. Biosurgery products minimize intra- and postoperative complications in a variety of treatments. These cutting-edge gadgets assist physicians in operating more effectively by decreasing surgery-related problems is costly and complex operations. The global biosurgery market is expected to develop significantly shortly as a result of increased investment, increased R&D spending, and aggressive methods used by top competitors such as new product launches. Various biosurgery products, such as hemostatic agents and surgical sealants, are increasingly being used in place of traditional sutures and staples during surgeries to control bleeding and cover the wound when using traditional goods is problematic or ineffective.
 
The market for biosurgery solutions is being driven by a growing focus on effective blood loss management and an increase in the number of elective surgeries. Globally, growth in elective surgical procedures can be ascribed to the prevalence of lifestyle problems and chronic diseases, as well as a growing geriatric population. Furthermore, the rising prevalence of severe traumatic injuries is fueling the demand for biosurgery products as a replacement for suture and ligature-based methods. Organic growth techniques such as new releases and developments are being used by vendors, resulting in a global increase in the availability of advanced items.

Segmentation


The global biosurgery market has been segmented on the basis of product, source, and application.


On the basis of product, the market has been classified as bone graft substitutes, hemostatic agents, soft-tissue attachments, surgical sealants and adhesives, adhesion barriers, and staple-line reinforcement agents. The bone-graft substitutes segment has been further divided into demineralized bone matrix, synthetic bone grafts, bone morphogenetic proteins, and other bone-graft substitutes. The hemostatic agents segment has been further divided into thrombin-based hemostatic agents, oxidized regenerated cellulose-based hemostatic agents, and combination hemostatic agents. The soft-tissue attachments segment has been classified as synthetic meshes and biological meshes. The surgical sealants and adhesives segment has been divided into natural and synthetic sealants and adhesives. The natural sealants sub-segment has been segmented into fibrin sealants, collagen-based sealants, gelatin-based sealants, albumin-based sealants, and other natural sealants. The synthetic sealants segment has been divided into peg hydrogels, cyanoacrylate-based sealants and adhesives, urethane-based sealants and adhesives, and others. Furthermore, the adhesion barriers segment has been sub-segmented into synthetic and natural adhesion barriers. The synthetic adhesion barriers segment includes hyaluronic acid-based, peg-based, and ther synthetic barriers. The natural adhesion barriers segment includes collagen- and fibrin-based adhesion barriers.


The biosurgery market, by source, has been segmented into biological and natural products. On basis of application, the market has been divided into neurological surgery, general surgery, cardiovascular surgery, orthopedic surgery, thoracic surgery, gynecology surgery, reconstructive surgery, and urology surgery.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The biosurgery market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The biosurgery market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Biosurgery Market Share, by Region, 2017 (%)


Biosurgery Market Share


Source: MRFR Analysis


The Americas are likely to dominate the global biosurgery market owing to the rising prevalence of chronic diseases in the aging population, increase in the number of surgical procedures, the presence of a well-established healthcare system, growing incidences of trauma-related injuries, and adoption of highly advanced technology. According to the American Association for the Surgery of Trauma, injury accounts for over 150,000 deaths and over 3 million non-fatal injuries are reported per year in the US.


The European market is expected to be the second-largest biosurgery market. The market growth in this region can be attributed to government funding and support of the healthcare sector coupled with increasing research and development. Moreover, a growing number of surgeries due to changing lifestyles is contributing to the growth of the market in this region.


Asia-Pacific is expected to be the fastest-growing biosurgery market during the forecast period owing to the increasing prevalence of chronic diseases, rising investments in healthcare and expansions by market players in the region. For instance, in February 2014, Cryolife, Inc. established a new subsidiary in Asia-Pacific.


The market in the Middle East & Africa is expected to account for the smallest share of the global biosurgery market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Company Profiles    



  • Baxter International, Inc.

  • Braun Melsungen AG

  • R. Bard

  • Johnson & Johnson

  • Medtronic, PLC.

  • MAQUET Holding B.V. & Co. Kg. (Getinge Group)

  • Cohera Medical Inc.

  • Integra Lifesciences Holdings Corporation

  • Commonwealth Serum Laboratories (CSL)

  • Hemostasis, LLC

  • Sanofi

  • Pfizer Inc.

  • Stryker Corporation

  • Cryolife, Inc.

  • Kuros Biosciences Ltd.


Research Methodology


Market Research Future analysis is conducted by industry experts who offer insight into industry structure, market segmentation, treatment assessment, competitive landscape (CL), market penetration, as well as on emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the biosurgery market will be headed in the next five to 10 years by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories are studied in each region and are estimated based on primary and secondary research.



  • Primary Research


Extensive primary research was conducted to gain a deeper insight into the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, marketing directors, and business development managers, among others) of the major players active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed over the next five to 10 years.



  • Secondary Research


Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the global biosurgery market. It was also used to obtain key information about major players, market classification and segmentation according to industry trends, regional markets, and developments related to the market and treatment perspectives. For this study, analysts have gathered information from various credible sources such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, international organizations of chemical manufacturers, and paid databases, among others.

Recent Development 


Peri-Strips Dry with Veritas Collagen Matrix product with Secure Grip received 510 (k) clearance from the US FDA in February 2020. This product is a staple line reinforcing agent that is used to control bleeding during bariatric and other surgical procedures. Integra LifeSciences Holdings Corp. also introduced AmnioExcel Plus Placental Allograft Membrane for soft tissue healing.
 
Orthofix Medical Inc. (US) released the O-GENESIS Graft Delivery System and AlloQuent Structural Allograft Q-Pack, ready-to-use cervical and lumbar spacers for allograft surgeries, in October 2020. This corporation is one of the top companies in terms of market share and currently controls the market.

Biosurgery Market, by Product



  • Bone-Graft Substitutes


    • Demineralized Bone Matrix

    • Synthetic Bone Grafts

    • Bone Morphogenetic Proteins

    • Other Bone-Graft Substitutes


  • Hemostatic Agents


    • Thrombin-Based Hemostatic Agents

    • Oxidized Regenerated Cellulose-Based Hemostatic Agents

    • Combination Hemostatic Agents


  • Soft-Tissue Attachments


    • Synthetic Meshes

    • Biological Meshes


  • Surgical Sealants and Adhesives


    •   Natural Sealants and Adhesives




  • Fibrin Sealants

  • Collagen-Based Sealants

  • Gelatin-Based Sealants

  • Albumin-Based Sealants

  • Other Natural Sealants




    •   Synthetic Sealants and Adhesives




  • Peg Hydrogels

  • Cyanoacrylate-Based Sealants and Adhesives

  • Urethane-Based Sealants and Adhesives

  • Other Synthetic Sealants



  • Adhesion Barriers


    •   Synthetic Adhesion Barriers




  • Hyaluronic Acid-Based Adhesion Barriers

  • Regenerated Cellulose-Based Adhesion Barriers

  • Peg-Based Adhesion Barriers

  • Ther Synthetic Adhesion Barriers




    • Natural Adhesion Barriers




  • Collagen and Protein Adhesion Barriers

  • Fibrin-Based Adhesion Barriers



  • Staple-Line Reinforcement Agents


Biosurgery Market, by Source



  • Biological Products

  • Synthetic Products


Biosurgery Market, by Application



  • Neurological Surgery

  • General Surgery

  • Cardiovascular Surgery

  • Orthopedic Surgery

  • Thoracic Surgery

  • Reconstructive Surgery

  • Urology Surgery


Biosurgery Market, by Region



  • Americas


    • North America


      • US

      • Canada


    • South America


  • Europe


    • Western Europe


      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe


    • Eastern Europe


  • Asia-Pacific


    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific


  • The Middle East & Africa


    • Middle East

    • Africa



Intended Audience



  • Biosurgery product manufacturers

  • Biosurgery product distributors and suppliers

  • Healthcare providers

  • Medical device manufacturers

  • Research institutes and academic centers

  • Contract research organizations (CROs)

  • Government associations

  • Market research and consulting



Report Scope:
Report Attribute/Metric Details
  Market Size   2030: Significant Value
  CAGR   8.40% (2020-2030)
  Base Year   2019
  Forecast Period   2020-2030
  Historical Data   2018
  Forecast Units    Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Product, Source, Application,
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Baxter International, Inc., B. Braun Melsungen AG, C.R. Bard, Johnson & Johnson, Medtronic, PLC., MAQUET Holding B.V. & Co. Kg. (Getinge Group), Cohera Medical Inc., Integra Lifesciences Holdings Corporation, Commonwealth Serum Laboratories (CSL), Hemostasis, LLC, Sanofi, Pfizer Inc., Stryker Corporation
  Key Market Opportunities   Increasing research, development and growing number of surgeries due to changing lifestyles is contributing to the growth of the market
  Key Market Drivers

  • Growing geriatric population, an increasing number of surgeries
  • Rising occurrences of trauma and sports-related injuries


  • Speak to Analyst Ask for Customization